321 related articles for article (PubMed ID: 17898325)
1. Prevalence and determinants of subclinical brain infarction: the Northern Manhattan Study.
Prabhakaran S; Wright CB; Yoshita M; Delapaz R; Brown T; DeCarli C; Sacco RL
Neurology; 2008 Feb; 70(6):425-30. PubMed ID: 17898325
[TBL] [Abstract][Full Text] [Related]
2. Prevalence, incidence, and risk factors of lacunar infarcts in a community sample.
Chen X; Wen W; Anstey KJ; Sachdev PS
Neurology; 2009 Jul; 73(4):266-72. PubMed ID: 19636046
[TBL] [Abstract][Full Text] [Related]
3. The growing specter of MRI-defined brain infarcts.
Longstreth WT; Vermeer SE
Neurology; 2008 Feb; 70(6):416-7. PubMed ID: 18250287
[No Abstract] [Full Text] [Related]
4. Association of serum soluble receptor for advanced glycation end-products with subclinical cerebrovascular disease: the Northern Manhattan Study (NOMAS).
Hudson BI; Moon YP; Kalea AZ; Khatri M; Marquez C; Schmidt AM; Paik MC; Yoshita M; Sacco RL; DeCarli C; Wright CB; Elkind MS
Atherosclerosis; 2011 May; 216(1):192-8. PubMed ID: 21316677
[TBL] [Abstract][Full Text] [Related]
5. Sex differences in the risk profile and male predominance in silent brain infarction in community-dwelling elderly subjects: the Sefuri brain MRI study.
Takashima Y; Miwa Y; Mori T; Hashimoto M; Uchino A; Yuzuriha T; Sasaguri T; Yao H
Hypertens Res; 2010 Jul; 33(7):748-52. PubMed ID: 20431593
[TBL] [Abstract][Full Text] [Related]
6. The prevalence and risk factor analysis of silent brain infarction in patients with first-ever ischemic stroke.
Oh SH; Kim NK; Kim SH; Kim JK; Kim HS; Kim WC; Kim OJ
J Neurol Sci; 2010 Jun; 293(1-2):97-101. PubMed ID: 20356606
[TBL] [Abstract][Full Text] [Related]
7. Lower prevalence of silent brain infarcts in the physically active: the Northern Manhattan Study.
Willey JZ; Moon YP; Paik MC; Yoshita M; Decarli C; Sacco RL; Elkind MS; Wright CB
Neurology; 2011 Jun; 76(24):2112-8. PubMed ID: 21653889
[TBL] [Abstract][Full Text] [Related]
8. Subclinical Cerebrovascular Disease Increases the Risk of Incident Stroke and Mortality: The Northern Manhattan Study.
Wright CB; Dong C; Perez EJ; De Rosa J; Yoshita M; Rundek T; DeCarli C; Gutierrez J; Elkind MSV; Sacco RL
J Am Heart Assoc; 2017 Aug; 6(9):. PubMed ID: 28847914
[TBL] [Abstract][Full Text] [Related]
9. Microalbuminuria is a risk factor for cerebral small vessel disease in community-based elderly subjects.
Wada M; Nagasawa H; Kurita K; Koyama S; Arawaka S; Kawanami T; Tajima K; Daimon M; Kato T
J Neurol Sci; 2007 Apr; 255(1-2):27-34. PubMed ID: 17320908
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and associated factors of silent brain infarcts in a Mediterranean cohort of hypertensives.
Delgado P; Riba-Llena I; Tovar JL; Jarca CI; Mundet X; López-Rueda A; Orfila F; Llussà J; Manresa JM; Alvarez-Sabín J; Nafría C; Fernández JL; Maisterra O; Montaner J;
Hypertension; 2014 Sep; 64(3):658-63. PubMed ID: 24958500
[TBL] [Abstract][Full Text] [Related]
11. Multiple Silent Brain Infarcts Are Associated with Severer Stroke in Patients with First-Ever Ischemic Stroke without Advanced Leukoaraiosis.
Chen DW; Wang YX; Shi J; Zhang WQ; Yang F; Yin YW; Ma LN
J Stroke Cerebrovasc Dis; 2017 Sep; 26(9):1988-1995. PubMed ID: 28688715
[TBL] [Abstract][Full Text] [Related]
12. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study.
Sacco RL; Kargman DE; Gu Q; Zamanillo MC
Stroke; 1995 Jan; 26(1):14-20. PubMed ID: 7839388
[TBL] [Abstract][Full Text] [Related]
13. Migraine as a risk factor for subclinical brain lesions.
Kruit MC; van Buchem MA; Hofman PA; Bakkers JT; Terwindt GM; Ferrari MD; Launer LJ
JAMA; 2004 Jan; 291(4):427-34. PubMed ID: 14747499
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast Growth Factor 23 Is Associated With Subclinical Cerebrovascular Damage: The Northern Manhattan Study.
Wright CB; Shah NH; Mendez AJ; DeRosa JT; Yoshita M; Elkind MS; Sacco RL; DeCarli C; Rundek T; Silverberg S; Dong C; Wolf M
Stroke; 2016 Apr; 47(4):923-8. PubMed ID: 26956260
[TBL] [Abstract][Full Text] [Related]
15. MTHFR gene polymorphism as a risk factor for silent brain infarcts and white matter lesions in the Japanese general population: The NILS-LSA Study.
Kohara K; Fujisawa M; Ando F; Tabara Y; Niino N; Miki T; Shimokata H;
Stroke; 2003 May; 34(5):1130-5. PubMed ID: 12690212
[TBL] [Abstract][Full Text] [Related]
16. Race and Ethnic Disparities in Stroke Incidence in the Northern Manhattan Study.
Gardener H; Sacco RL; Rundek T; Battistella V; Cheung YK; Elkind MSV
Stroke; 2020 Apr; 51(4):1064-1069. PubMed ID: 32078475
[TBL] [Abstract][Full Text] [Related]
17. Paradoxical embolism as a cause of silent brain infarctions in healthy subjects: the ICONS study (Identification of the Cause of Silent Cerebral Infarction in Healthy Subjects).
Kim SJ; Shin HY; Ha YS; Kim JW; Kang KW; Na DL; Bang OY
Eur J Neurol; 2013 Feb; 20(2):353-60. PubMed ID: 22958084
[TBL] [Abstract][Full Text] [Related]
18. Left ventricular mass-geometry and silent cerebrovascular disease: The Cardiovascular Abnormalities and Brain Lesions (CABL) study.
Nakanishi K; Jin Z; Homma S; Elkind MS; Rundek T; Tugcu A; Yoshita M; DeCarli C; Wright CB; Sacco RL; Di Tullio MR
Am Heart J; 2017 Mar; 185():85-92. PubMed ID: 28267479
[TBL] [Abstract][Full Text] [Related]
19. Early menopause and the risk of silent brain infarction in community-dwelling elderly subjects: the Sefuri brain MRI study.
Fukuda K; Takashima Y; Hashimoto M; Uchino A; Yuzuriha T; Yao H
J Stroke Cerebrovasc Dis; 2014; 23(5):817-22. PubMed ID: 24045081
[TBL] [Abstract][Full Text] [Related]
20. Risk factors and prevention of lacunar infarcts in 60- to 64-year-olds.
Kaufman JL; Karceski S
Neurology; 2009 Jul; 73(4):e17-9. PubMed ID: 19636044
[No Abstract] [Full Text] [Related]
[Next] [New Search]
